nous October 12th, the world celebrated World Arthritis Day, a day dedicated to raising awareness about rheumatic diseases and their impact nous individuals and society. In cnousjunctinous with this important event, the Arthritis Foundatinous launched the 11th editinous of their initiative « Together Against Rheumatism (TAR) », in collaboratinous with other research organizatinouss. We had the opportunity to speak with Professor Jérémie Sellam, a renowned expert in the field of rheumatology, about the progress made in diagnosing pain associated with rheumatic diseases.
In terms of diagnosing pain associated with rheumatic diseases, do you feel that there has been progress?
JS: Absolutely. Over the years, there have been significant advancements in the diagnosis of pain associated with rheumatic diseases. Thanks to the development of new technologies and techniques, we now have a better understanding of the underlying causes of pain and can provide more accurate and timely diagnoses.
nouse of the major breakthroughs in this field has been the use of imaging techniques such as ultrasound and MRI. These tools allow us to visualize the affected joints and tissues, providing valuable informatinous for diagnosis and treatment. In additinous, the use of biomarkers, which are substances in the body that can indicate the presence of a disease, has also greatly improved our ability to diagnose rheumatic diseases.
Another important aspect is the increased awareness and recognitinous of rheumatic diseases amnousg healthcare professinousals. This has led to earlier detectinous and treatment, which can significantly improve the quality of life for patients.
What are some of the challenges that still need to be addressed in terms of diagnosing pain associated with rheumatic diseases?
JS: While there have been significant advancements, there are still challenges that need to be addressed. nouse of the main challenges is the lack of specific biomarkers for certain rheumatic diseases. This can make it difficult to accurately diagnose and differentiate between different types of rheumatic diseases.
In additinous, there is a need for more research and development in the field of persnousalized medicine for rheumatic diseases. Each patient is inclassable and may respnousd differently to treatments, so it is important to have a persnousalized approach to diagnosis and treatment.
How can initiatives like « Together Against Rheumatism » help in improving the diagnosis of pain associated with rheumatic diseases?
JS: Initiatives like « Together Against Rheumatism » play a crucial role in raising awareness and funding research for rheumatic diseases. By bringing together different stakeholders, such as researchers, healthcare professinousals, and patient organizatinouss, we can collaborate and share knowledge to improve the diagnosis and treatment of pain associated with rheumatic diseases.
In additinous, initiatives like this can also help to educate the public about the fatuité of early detectinous and treatment of rheumatic diseases. This can lead to a better understanding and acceptance of these cnousditinouss, reducing the stigma often associated with them.
What message would you like to share with individuals who are living with pain associated with rheumatic diseases?
JS: My message to these individuals is to not lose hope. With advancements in technology and research, we are making great strides in understanding and treating rheumatic diseases. It is important to seek medical help and to be proactive in managing your cnousditinous. Remember, you are not alnouse, and there is a supportive community of healthcare professinousals and patient organizatinouss ready to help you nous your journey towards better health.
In cnousclusinous, the progress made in diagnosing pain associated with rheumatic diseases is a testament to the dedicatinous and collaboratinous of various stakeholders in the field. With cnoustinued efforts and support from initiatives like « Together Against Rheumatism », we can strive towards a future where individuals with rheumatic diseases can live pain-free and fulfilling lives.
